Fig1. Structure of MHC molecules.

MHC Class I Molecule

 It is composed of α chain (glycoprotein, 45kDa) coded by HLA class I genes and β2 microglobulin (non-glycosylated 12 kDa protein, encoded by a non MHC gene from chromosome 15).

* The α chain is folded further and organized into three extracellular globular domains—α1, α2 and α3 (each containing 90 amino acids) and a cytoplasmic tail

* The association of β2 microglobulin with α chain is necessary for the expression  of MHC I molecules on to the cell surface. In Daudi cells (a type of human B cell tumor cell which are not able to produce β2 microglobulin), it is observed that they synthesize MHC-I but do not express them on cell surface.

 Role of MHC Class I Molecules

* The antigen peptide binding groove of class I MHC molecule (i.e. the site, where the antigen peptide binds) is formed by the cleft between α1 and α2 domains

* The α3 domain binds to CD8 molecule present on cytotoxic T cells during antigen presentation.

 MHC Class II Molecule

 It comprises of one α chain (33 kDa) and one β chain (28 kDa). The α and β chains in turn consist of two domains each—(1) α1 and α2 and (2) β1 and β2, respectively and cytoplasmic tails.

* The antigen peptide binding groove is formed by the cleft between α1 and β1 domains

* The β2 domain interacts with CD4 molecule of helper T cells during antigen presentation.

 Differences between MHC class I and II molecules are described in Table 1.

Table1. Differences between MHC class I and MHC class II molecules.

Regulation of MHC Expression

 There are several regulatory mechanisms that control the expression of MHC genes in different cell types.

* Transcription factors: MHC genes have promoter sequences at their 5’ end which are regulated by certain transcription factors such as CIITA, and RFX (both bind to MHC II promoter genes and increase their transcription). Defects in CIITA, and RFX cause one of the form of Bare lymphocyte syndrome

* Cytokines also influence MHC expression

- IFN-γ activates both MHC-I and II promoter genes

- IL-4 increases expression of class II MHC molecules on resting B cells.

* Corticosteroid and prostaglandins decrease the expression of MHC II molecules

* In many viral infections, the viral antigens inhibit various components of MHC-I (e.g. adenovirus proteins inhibit TAP, cytomegalovirus proteins inhibit β2 microglobulin). As a result, MHC-I expression is suppressed.

MHC and Disease Susceptibility

 Many HLA alleles have been associated with increased susceptibility to certain diseases (Table 2). The relative risk of occurrence of the disease in presence of the identified allele varies. For example, HLA B27 is strongly associated with ankylosing spondylitis (90 times higher risk than those not expressing HLA B 27).

Table2. Diseases associated with certain HLA alleles.

اخر الاخبار

اخبار العتبة العباسية المقدسة

قسم شؤون المعارف ينظم دورة متقدمة في تحقيق المخطوطات لملاكاته

قسم الشؤون الفكرية يصدر العدد العشرين من مجلة دراسات إفريقية

المجمَع العلمي يكرم الأساتذة المشاركين في مشروع الدورات القرآنية الصيفية في كربلاء

العتبة العباسية المقدسة تختتم فعاليات البرنامج المركزي الأسبوعي لمنتسبيها

المزيد

الآخبار الصحية

تحذير من "عدوى بكتيرية" تسبب نوبات قلبية

ماذا يحصل لجسمك عند التوقف عن استخدام الزيت في الطهي؟

الأمل في كبسولة.. "فيتامين شهير" يبطئ التقدم في العمر

اشتهاء أطعمة بشكل مفاجئ.. ناقوس خطر للسرطان ؟!

المزيد

الآخبار التكنلوجية

زلزال أفغانستان يحصد أكثر من ألف قتيل.. ويدمر آلاف المنازل !

ناجٍٍ وحيد من انزلاق أرضي.. دمّر قرية سودانية بأكملها !

نهر الفرات.. مورد مائي بين الندرة والتقاسم

ما السر وراء مشية إيلون ماسك الغريبة والسريعة ؟

المزيد

مواضيع ذات صلة

Antigen presentation

Cytokines

MHC Genes and Their Products

Macrophage

B Lymphocytes

T Lymphocytes

Immunologic Manifestations of Infectious Mononucleosis

Peripheral Lymphoid Organs

Central Lymphoid Organs

Effector Functions of Complement

Complement Pathways

Mechanisms of innate immunity